All > Neuropathy > Peripheral Neuropathy

Transcutaneous Electrical Nerve Stimulation for Peripheral Neuropathy

Emory University/Winship Cancer Institute, Atlanta, GA
Peripheral Neuropathy+21 More ConditionsTranscutaneous Electrical Nerve Stimulation - Other
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial is testing if TENS, a mild electrical current applied to the skin, can help improve neuropathy symptoms for stage I-III breast cancer patients on chemotherapy.

Eligible Conditions
  • Chemotherapy-induced Peripheral Neuropathy
  • Stage 1 Breast Cancer
  • Stage IB Breast Cancer
  • Stage III Breast Cancer
  • Stage IIIA Breast Cancer
  • Stage IIIB Breast Cancer
  • Stage II Breast Cancer
  • Stage IA Breast Cancer
  • Breast Cancer
  • Stage IIA Breast Cancer
  • Stage IIB Breast Cancer
  • Stage 2 Breast Cancer

Treatment Effectiveness

Phase-Based Effectiveness

1 of 3
N/A

Similar Trials

1
WST-057 Active
1
Palmidrol
1
Transcutaneous Electrical Nerve Stimulation (TENS)

Study Objectives

1 Primary · 7 Secondary · Reporting Duration: At baseline and 2 and 6 weeks

Week 6
Change in Monofilament Testing
Change in Patient Reported Outcomes Measurement Information System (PROMIS)29 score
Change in Patient Reported Outcomes Measurement Information System 29 score
Week 2
Change in Chemotherapy Induced Peripheral Neuropathy (CIPN)20 Sensory Sub-Score
Week 2
Change in Numbness Scores
Change in Pain Scores
Change in Tingling Scores
Up to 2 weeks
Evaluate the Feasibility of Daily TENS by Measuring Participant Adherence to TENS for Two Weeks

Trial Safety

Phase-Based Safety

1 of 3

Similar Trials

2
WST-057 Active
2
Palmidrol
1
Transcutaneous Electrical Nerve Stimulation (TENS)

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

1 Treatment Group

Supportive Care (TENS)
1 of 1

Experimental Treatment

27 Total Participants · 1 Treatment Group

Primary Treatment: Transcutaneous Electrical Nerve Stimulation · No Placebo Group · N/A

Supportive Care (TENS)
Other
Experimental Group · 1 Intervention: Transcutaneous Electrical Nerve Stimulation · Intervention Types: Other

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: at baseline and 2 and 6 weeks

Who is running the clinical trial?

Emory UniversityLead Sponsor
1,558 Previous Clinical Trials
2,765,714 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,275 Previous Clinical Trials
41,234,664 Total Patients Enrolled
15 Trials studying Peripheral Neuropathy
1,555 Patients Enrolled for Peripheral Neuropathy
Manali Bhave, MDPrincipal InvestigatorEmory University Hospital/Winship Cancer Institute

Eligibility Criteria

Age 18+ · All Participants · 0 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
References

Frequently Asked Questions

What is the participant capacity for this investigation?

"That is accurate. According to clinicaltrials.gov, the trial that was initially posted on October 19th 2022 is currently recruiting participants. 27 patients must be accepted from 3 separate medical centres." - Anonymous Online Contributor

Unverified Answer

Are participants currently being enrolled for this clinical investigation?

"According to the information listed on clinicaltrials.gov, the recruitment for this trial is ongoing and continues since its original posting date of October 19th 2022. The data was last revised on November 21st 202" - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top